MSK2 was phosphorylated in bioprinted cells, and this is putatively assisting regulation of glycogen metabolism, which is key to cell survival of chemotherapeutic treatments, as glucose is largely metabolized by glycolysis in cancer cells. Here, RPS6KA4 is linked to cancer.